Save your place

Sign in to WhoBought

Please try again later.

Krystal Biotech, Inc. (KRYS) institutional ownership

Latest close $365.81 Jul 10, 2026
Market cap$7.8B 52-week range SectorHealthcare
Funds holding · Q1 2026
343
reported KRYS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $32M
202 buyers · 141 sellers

Krystal Biotech, Inc. (KRYS) price and institutional activity

Dates

Q1 2026

$412M bought by 202 investors
Soleus Capital Management, L.P.$56MInvesco Ltd.$51M +200 more
$444M sold by 141 investors
Citadel Advisors LLC-$102MNorges-$76M +139 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Krystal Biotech, Inc. (KRYS) institutional activity · 343

Investor Type Est. change Change Δ Own Date
Citadel Advisors LLC Reduced· Q1 2026 −$102M −384K −99.3% Q1 2026
Norges · Exited −$76M
Change −285K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$76M −285K −100.0% Q1 2026
Soleus Capital Management, L.P. · Added +$56M
Change +212K Date Q1 2026
Soleus Capital Management, L.P. Added· Q1 2026 +$56M +212K Q1 2026
Invesco Ltd. · Added +$51M
Change +191K Δ Own +318.9% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +$51M +191K +318.9% Q1 2026
Marshall Wace, LLP · Reduced −$31M
Change −115K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −$31M −115K Q1 2026
First Trust Advisors LP · Added +$28M
Change +105K Date Q1 2026
First Trust Advisors LP Added· Q1 2026 +$28M +105K Q1 2026
Raymond James Financial Inc · Added +$21M
Change +80K Date Q1 2026
Raymond James Financial Inc Added· Q1 2026 +$21M +80K Q1 2026
Goldman Sachs Group Inc · Reduced −$21M
Change −79K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$21M −79K Q1 2026
Bellevue Group AG · Added +$19M
Change +71K Date Q1 2026
Bellevue Group AG Added· Q1 2026 +$19M +71K Q1 2026
Bank of America Corp · Added +$19M
Change +70K Date Q1 2026
Bank of America Corp Added· Q1 2026 +$19M +70K Q1 2026
Vanguard · Added +$16M
Change +60K Date Q1 2026
Vanguard Added· Q1 2026 +$16M +60K Q1 2026
Barclays PLC · Reduced −$15M
Change −55K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −$15M −55K Q1 2026
Orbimed Advisors LLC · Reduced −$14M
Change −51K Date Q1 2026
Orbimed Advisors LLC Reduced· Q1 2026 −$14M −51K Q1 2026
Janus Henderson Group PLC · Added +$13M
Change +47K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +$13M +47K Q1 2026
Skandinaviska Enskilda Banken AB (publ) · Exited −$12M
Change −47K Δ Own −100.0% Date Q1 2026
Skandinaviska Enskilda Banken AB (publ) Exited· Q1 2026 −$12M −47K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 343

Famous investor activity in Krystal Biotech, Inc. (KRYS)

Krystal Biotech, Inc. (KRYS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Thomas John Charles · Officer Sell −$347K
Price $347.27 Qty −1K Owned 0 ΔOwn −100.0% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Thomas John Charles Officer Sell $347.27 −1K −$347K 0 −100.0% Jun 25, 2026 Jun 26, 2026
Thomas John Charles · Officer 2 operations 0
Price $179.25 Owned 6K Trade date Jun 25, 2026 Filed date Jun 26, 2026
Thomas John Charles Officer 2 operations $179.25 0 6K Jun 25, 2026 Jun 26, 2026
Krishnan Suma · Director 11 operations −$7.7M
Price $300.75–$311.65 Qty −25K Owned 1.4M Trade date Jun 4, 2026 Filed date Jun 5, 2026
Krishnan Suma Director 11 operations $300.75–$311.65 −25K −$7.7M 1.4M Jun 4, 2026 Jun 5, 2026
Krishnan Krish S. · Director 11 operations −$7.7M
Price $300.75–$312.23 Qty −25K Owned 1.5M Trade date Jun 4, 2026 Filed date Jun 5, 2026
Krishnan Krish S. Director 11 operations $300.75–$312.23 −25K −$7.7M 1.5M Jun 4, 2026 Jun 5, 2026
Thomas John Charles · Officer Sell −$194K
Price $302.03 Qty −642 Owned 0 Trade date May 26, 2026 Filed date May 27, 2026
Thomas John Charles Officer Sell $302.03 −642 −$194K 0 May 26, 2026 May 27, 2026
Krishnan Suma · Director, Officer, 10% Owner 10 operations −$6.6M
Price $257.32–$266.42 Qty −25K Owned 1.4M Trade date Mar 4, 2026 Filed date Mar 6, 2026
Krishnan Suma Director, Officer, 10% Owner 10 operations $257.32–$266.42 −25K −$6.6M 1.4M Mar 4, 2026 Mar 6, 2026
Krishnan Krish S. · Director, Officer, 10% Owner 10 operations −$6.6M
Price $257.31–$266.56 Qty −25K Owned 1.5M Trade date Mar 4, 2026 Filed date Mar 6, 2026
Krishnan Krish S. Director, Officer, 10% Owner 10 operations $257.31–$266.56 −25K −$6.6M 1.5M Mar 4, 2026 Mar 6, 2026
Romano Kathryn · Officer Sell −$201K
Price $267.60 Qty −750 Owned 22K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Romano Kathryn Officer Sell $267.60 −750 −$201K 22K Mar 2, 2026 Mar 3, 2026
Romano Kathryn · Officer 4 operations 0
Owned 0 Trade date Feb 27, 2026 Filed date Mar 3, 2026
Romano Kathryn Officer 4 operations 0 0 Feb 27, 2026 Mar 3, 2026
Romano Kathryn · Officer 2 operations -$965K
Price $275.64 Qty -4K Owned 23K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Romano Kathryn Officer 2 operations $275.64 -4K -$965K 23K Feb 27, 2026 Mar 3, 2026
Romano Kathryn · Officer 2 operations 19K
Owned 14K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Romano Kathryn Officer 2 operations 19K 14K Feb 27, 2026 Mar 3, 2026
Krishnan Suma · Director, Officer, 10% Owner 7 operations 41K
Owned 0 Trade date Feb 27, 2026 Filed date Mar 3, 2026
Krishnan Suma Director, Officer, 10% Owner 7 operations 41K 0 Feb 27, 2026 Mar 3, 2026
Krishnan Suma · Director, Officer, 10% Owner 5 operations -$8.4M
Price $275.64 Qty -31K Owned 1.5M Trade date Feb 27, 2026 Filed date Mar 3, 2026
Krishnan Suma Director, Officer, 10% Owner 5 operations $275.64 -31K -$8.4M 1.5M Feb 27, 2026 Mar 3, 2026
Krishnan Suma · Director, Officer, 10% Owner 3 operations 69K
Owned 44K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Krishnan Suma Director, Officer, 10% Owner 3 operations 69K 44K Feb 27, 2026 Mar 3, 2026
Krishnan Krish S. · Director, Officer, 10% Owner 8 operations 26K
Owned 17K Trade date Feb 27, 2026 Filed date Mar 3, 2026
Krishnan Krish S. Director, Officer, 10% Owner 8 operations 26K 17K Feb 27, 2026 Mar 3, 2026
15 of 31
15 of 31 Sign in to continue to older insider transactions.

Krystal Biotech, Inc. (KRYS) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 4.3M
% of shares outstanding 14.9% Filing date Nov 12, 2024
FMR LLC 4.3M 14.9% Nov 12, 2024
BlackRock Inc. 3.9M
% of shares outstanding 13.8% Filing date Jul 8, 2024
BlackRock Inc. 3.9M 13.8% Jul 8, 2024
Krish S. Krishnan 3.4M
% of shares outstanding 11.5% Filing date May 4, 2026
Krish S. Krishnan 3.4M 11.5% May 4, 2026
Vanguard Group Inc 2.9M
% of shares outstanding 10.1% Filing date Jul 10, 2024
Vanguard Group Inc 2.9M 10.1% Jul 10, 2024
Avoro Capital Advisors LLC 2.6M
% of shares outstanding 9.1% Filing date Feb 14, 2024
Avoro Capital Advisors LLC 2.6M 9.1% Feb 14, 2024
State Street Corp 1.5M
% of shares outstanding 5.1% Filing date Oct 16, 2024
State Street Corp 1.5M 5.1% Oct 16, 2024
Vanguard Portfolio Management 1.5M
% of shares outstanding 5.0% Filing date Apr 29, 2026
Vanguard Portfolio Management 1.5M 5.0% Apr 29, 2026
Redmile Group, LLC 810K
% of shares outstanding 2.8% Filing date Nov 14, 2024
Redmile Group, LLC 810K 2.8% Nov 14, 2024
8 of 9

Krystal Biotech, Inc. (KRYS) ownership FAQ

Who owns KRYS?

343 reporting institutions disclosed KRYS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.